Table 2.
Women (n=148) | Men (n=1064) | P-value | |
---|---|---|---|
| |||
LV Function | |||
LVEF, % | 30.0 (25.0, 35.6) | 27.0 (22.0, 33.0) | 0.0001 |
ESVI, mL/m2 | 70.0 (53.0, 89.3) | 80.2 (62.5, 102.6) | <0.0001 |
EDVI, mL/m2 | 97.4 (79.1, 119.2) | 113.9 (91.1, 141.8) | <0.0001 |
| |||
Anterior akinesis or dyskinesis | 43.0 (29.0, 57.0) | 43.0 (25.0, 57.0) | 0.270 |
| |||
Mitral Regurgitation | 0.026 | ||
None or trace | 27.7% | 37.1% | |
Mild | 50.7% | 45.1% | |
Moderate | 16.9% | 14.7% | |
Severe | 4.7% | 3.0% | |
| |||
Number of vessels with ≥75% stenosis | 0.617 | ||
None | 2.7% | 2.0% | |
1 | 29.1% | 22.5% | |
2 | 29.1% | 39.4% | |
3 | 39.2% | 36.1% | |
| |||
Multi-vessel disease | 68.2% | 75.5% | 0.056 |
| |||
Left main stenosis ≥50% | 3.4% | 2.5% | 0.581 |
| |||
Proximal LAD ≥75% | 64.2% | 68.8% | 0.262 |
Median (twenty-fifth, seventy-fifth percentiles) for continuous variables. Clinical values are the best available data reported by participating sites. EDVI, end diastolic volume index; ESVI, end systolic volume index; LAD, left anterior descending artery; LVEF indicates left ventricular ejection fraction.